FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq L

RBC Capital analyst Lisa Walter maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Outperform a

Mirum Pharmaceuticals is evolving into a leading liver disease franchise, with robust revenue growth

JP Morgan analyst Jessica Fye maintains Mirum Pharmaceuticals (NASDAQ:MIRM) with a Overweight and

Mirum Pharmaceuticals (MIRM) saw its shares surge in the last session with trading volume being high

After a sweeping semi-annual rebalance, the biotech index underlying the ALPS Medical Breakthroughs

Mirum and Incyte's zilurgisertib cut new bone lesion formation in rare disease FOP, as the FDA begin

Mirum and Incyte's zilurgisertib cut new bone lesion formation in rare disease FOP, as the FDA begin

Mirum and Incyte's zilurgisertib cut new bone lesion formation in rare disease FOP, as the FDA begin

Mirum Pharmaceuticals, Inc. (Nasdaq:MIRM) and Incyte (Nasdaq:INCY) today announced pivotal Phase 2 r

FOSTER CITY, Calif. & WILMINGTON, Del.--(BUSINESS WIRE)--Mirum Pharmaceuticals and Incyte Announce P

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq L

Mirum Pharmaceuticals (MIRM) reported earnings 30 days ago. What's next for the stock?

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) and Incyte (Nasdaq: INCY) today announced that pivotal Ph

FOSTER CITY, Calif. & WILMINGTON, Del.--(BUSINESS WIRE)--Mirum and Incyte Announce Pivotal Late-Brea

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced new data

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Announces New Data from Rare Liver Disea

Mirum Pharmaceuticals NASDAQ: MIRM executives said the rare disease company is entering a catalyst-h

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals to Present Data Showcasing Leadership in

Mirum Pharmaceuticals NASDAQ: MIRM is a late-stage biotechnology company that is making significant

Top Wall Street analysts upgraded STUB, PGNY, AMT, and BAP stocks and raised their price targets. Se

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq L

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Prices $600.0 Million Convertible Senior

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings

Stocks That Hit 52-Week Highs On Tuesday

Stocks that Broke 52-Week Highs Tuesday